Donald Trump’s assertion linking paracetamol to autism in babies has drawn criticism from the scientific and medical communities. The US administration, led by President Trump, has advised pregnant women to avoid paracetamol in the early stages of pregnancy, citing concerns about the role of medication in the rise of autism cases. However, NHS guidelines maintain that paracetamol is a safe pain relief option during pregnancy and is crucial for managing pain and fever, which could pose risks if left untreated.
The Mirror delves into the assertions made by the US administration and examines the scientific basis behind them. President Trump’s recent press conference at the Oval Office created a stir within the global scientific community as he claimed to have uncovered the key to autism. He was accompanied by Health Secretary Robert F Kennedy Jr, known for promoting anti-vaccine conspiracy theories in the past.
Trump’s declaration, labeling paracetamol as ineffective and advising against its prescription for pregnant women, has raised concerns among experts. While he emphasized the need to address autism swiftly, experts caution that the disorder’s causes are multifaceted and not easily pinpointed to a single factor.
Research has shown a significant increase in autism diagnoses over the past two decades, with the condition varying in severity and affecting individuals differently. While studies have explored potential environmental triggers for autism, conclusive evidence linking paracetamol use during pregnancy to autism remains elusive. Despite some studies suggesting a marginal association, the broader scientific consensus indicates no direct causal link.
Experts emphasize the importance of weighing the risks and benefits of using paracetamol during pregnancy, highlighting its long-standing safety record. Concerns have been raised that Trump’s directive may hinder access to essential pain relief for pregnant women and potentially harm unborn babies. The broader medical community urges a cautious approach, stressing the need for evidence-based decision-making in healthcare practices.